Association of KEAP1 and NFE2L2 polymorphisms with temporal lobe epilepsy and drug resistant epilepsy
Association of KEAP1 and NFE2L2 polymorphisms with temporal lobe epilepsy and drug resistant epilepsy
复制标题
KEAP1和NFE2L2多态性与颞叶癫痫和耐药性癫痫的关联
DOI:
10.1016/j.gene.2015.06.055
复制
发表时间:
2015
期刊:
影响因子:
3.5
通讯作者:
Keshen Li
中科院分区:
文献类型:
--
作者:
Zhou Liu;Xiaojian Yin;Lingying Liu;Hua Tao;Haihong Zhou;Guoda Ma;Lili Cui;You Li;Shuyan Zhang;Zhi&39;en Xu;LiFen Yao;Zhiyou Cai;Bin Zhao;Keshen Li
Background and aimsTemporal lobe epilepsy (TLE) is a prevalent form of epilepsy. TLE contributes to the majority of drug resistant epilepsy (DRE) cases and is associated with genetic factors. Kelch-like ECH-associated protein 1 (KEAP1)/Nuclear erythroid 2-related factor 2 (known as NFE2L2 or Nrf2) association has been implicated in neuroprotection due to induction of antioxidant enzymes. The association of one singleKEAP1gene nucleotide polymorphism (SNP) and nineNFE2L2gene SNPs with TLE and DRE were examined to determine whether these SNPs influenced the risk of TLE and DRE in a Han population.Subjects and methodsA total of 184 TLE patients (including 72 DRE patients) and 183 controls were included in this analysis. The SNaPshot Multiplex kit was used to assess the genotypes.ResultsANFE2L2gene haplotype was identified as a risk factor for TLE (OR = 7.11, 95% CI 1.53–32.98). Additionally, rs2706110 G > A in theNFE2L2gene and rs1048290 C > G in theKEAP1gene showed a significant risk for and a protective effect against DRE, respectively.ConclusionOur findings suggest that variations inNFE2L2gene increase the risk of TLE and DRE but that variations inKEAP1gene play a protective role for DRE.